Phio Pharmaceuticals (PHIO) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Phio Pharmaceuticals Corp  (NASDAQ: PHIO)


Phio Pharmaceuticals's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Phio Pharmaceuticals's ROA in the second quarter of 2026?
Phio Pharmaceuticals Corp recorded a cumulative net loss of $-13 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -79.76%.

However, within the Healthcare sector 691 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4129, from total ROA ranking in the first quarter of 2026 at 4700.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 26.6 % 29.55 % 274.47 % 96.16 % 113.39 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -13 -11 -9 -8 -7
Return On Assets (TTM) -79.76 % -70.87 % -60.26 % -75.77 % -77.98 %
PHIO's Total Ranking # 4129 # 4700 # 4251 # 4329 # 4467
Total Assets (TTM) in million 14 17 21 12 11
Seq. Total Assets Change -17.83 % -18.96 % 86.76 % 1.81 % -15.92 %
Seq. Net Income Change - - - - -

PHIO's 5 Years Annual ROA >> Back to PHIO Management Effectiveness >> Compare PHIO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 314
Sector # 692
Overall # 4139

Return On Assets Statistics
High Average Low
-43.68 %
-95.53 %
-245.72 %
(Jun 30 2021)   (Jun 30 2013)



  News about Phio Pharmaceuticals Corp Return on Assets ROA

Phio Pharmaceuticals Sets Sights on Financial Turnaround with New CFO at the Helm

In recent news, Phio Pharmaceuticals Corp (NASDAQ: PHIO), a clinical stage biotechnology company, has announced the appointment of a new Chief Financial Officer (CFO). This move comes as the company strives to improve its financial performance, which has been plagued by a cumulative net loss of $9 million during the 12 months ending in the first quarter of 2024. With a negative return on assets (ROA) of -98.58%, Phio Pharmaceuticals faces challenges in the healthcare sector, where 539 other companies boast higher ROAs. However, there is hopeful news as the company s ROA ranking has shown improvement, climbing from 3896 in the fourth quarter of 2023 to 3406 in the first quarter of 2024.New CFO to Drive Financial Growth:Phio Pharmaceuticals has recently appointed a new Chief Financial Officer, a strategic decision aimed at bolstering financial performance. The company s choice of CFO signifies its commitment to addressing the net loss and improving the ROA. With extensive experience in the biotechnology industry, the new CFO is expected to bring valuable insights and create innovative financial strategies to guide Phio Pharmaceuticals towards profitability.



Financial Statements
Phio Pharmaceuticals's Assets $ 14 million PHIO's Balance sheet
Phio Pharmaceuticals's Income $ -4 million Quarterly PHIO's Income Statement
PHIO's Income by Division See PHIO's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 274.47 % -38.72 % -26.92 % -49.09 % 59.92 %
Total Assets in million 21 6 9 13 25
Y / Y Net Income Change - - - - -
Net Income in million -9 -7 -11 -11 -13
Annual Return On Assets -40.48 % -124.61 % -115.61 % -89.59 % -52.79 %

PHIO's 5 Years Annual ROA >> Back to PHIO Management Effectiveness >> Compare PHIO ROA to its Competitors



More Return On Assets Ratios
PHIO's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PHIO's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PHIO's Competitors
Subscribers only: Roa for Phio Pharmaceuticals's Suppliers
Subscribers only: Return On Assets for PHIO's Customers

You may also want to know
PHIO's Roi PHIO's Inventory Turnover Ratio PHIO's Growth Rates PHIO's Dividend Comparisons
PHIO's Profitability Ratios PHIO's Asset Turnover Ratio PHIO's Dividend Growth
PHIO's Roe PHIO's Valuation Ratios PHIO's Financial Strength Ratios PHIO's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T20:02:23+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.